Kyverna Therapeutics, Inc. (KYTX) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$169.83M | -19.1% |
| 2024 | -$142.60M | -128.5% |
| 2023 | -$62.41M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$169.83M | -19.1% |
| 2024 | -$142.60M | -128.5% |
| 2023 | -$62.41M | — |